# Expert Perspectives on Enhancing Analytical Methods for Multi-Ingredient Dietary Supplements (MIDS): A Qualitative Study

**Authors:** Ingyeong Ko, Hae Jin Park, Kwang Suk Ko, Hyunsoo Kim, Jieun Oh

PMC · DOI: 10.3390/foods14213598 · Foods · 2025-10-22

## TL;DR

This study explores challenges in testing multi-ingredient dietary supplements and suggests ways to improve analytical methods and standardization.

## Contribution

The paper presents expert insights and practical strategies for improving analytical reliability in multi-ingredient dietary supplement testing.

## Key findings

- Experts identified major obstacles like degradation of trace components and lack of standardized protocols.
- Companies use varied internal strategies to address analytical challenges, highlighting the need for a unified framework.
- Proposed solutions include matrix-specific protocols, optimized extraction, and regulatory harmonization.

## Abstract

The increasing demand for multi-ingredient dietary supplements (MIDS), driven by diverse consumer health needs, has introduced analytical challenges in product testing and quality control. These challenges stem from complex ingredient interactions, formulation variability, and the diverse physicochemical properties of the individual components. To examine these issues and explore practical solutions, this study employed semi-structured focus group interviews with 33 industry professionals and 10 analytical experts from academic and industry. Professionals reported major obstacles including the degradation or loss of trace components, interferences among ingredients, analytical difficulties with specific dosage forms, and the lack of standardized testing protocols. To mitigate these challenges, professionals reported implementing various combination strategies including substituting problematic raw materials and modifying analytical instruments and pretreatment procedures, in order to improve test reproducibility. These measures were developed internally and varied significantly across companies, reflecting the absence of a unified analytical framework for MIDS testing. Building on these insights, the analytical experts proposed systematic improvements including developing matrix-specific pretreatment protocols and optimized extraction strategies as well as regulatory harmonization to enhance analytical reliability and reproducibility. These findings provide critical insights into current field practices and inform the development of standardized methodologies for the analysis and quality assurance of MIDS.

## Full-text entities

- **Diseases:** injury to (MESH:D014947), COVID-19 (MESH:D000086382), MIDS (MESH:D015161), overdose (MESH:D062787)
- **Chemicals:** astaxanthin (MESH:C005948), Vitamin K2 (MESH:D024482), acid (MESH:D000143), Rosavin (MESH:C529148), copper sulfate (MESH:D019327), acetone (MESH:D000096), dichloromethane (MESH:D008752), phosphate (MESH:D010710), chloroform (MESH:D002725), zeaxanthin (MESH:D065146), water (MESH:D014867), pantothenic acid (MESH:D010205), Folic acid (MESH:D005492), Vitamin D (MESH:D014807), selenium (MESH:D012643), phospholipid (MESH:D010743), flavonoid (MESH:D005419), iodine (MESH:D007455), beta-carotene (MESH:D019207), amino acids (MESH:D000596), Catechins (MESH:D002392), magnesium (MESH:D008274), Vitamin K (MESH:D014812), propolis (MESH:D011429), vitamin B2 (MESH:D012256), rice bran extract (MESH:D000073879), CoQ10 (MESH:C024989), nitrogen (MESH:D009584), NaOH (MESH:D012972), Vitamin B12 (MESH:D014805), lutein (MESH:D014975), glutathione (MESH:D005978), biotin (MESH:D001710), carotenoids (MESH:D002338), Vitamin C (MESH:D001205), Rg3 (-), Ginsenosides (MESH:D036145)
- **Species:** Malpighia glabra (species) [taxon 71611], Silybum marianum (blessed milkthistle, species) [taxon 92921], Serenoa repens (saw palmetto, species) [taxon 4722], Homo sapiens (human, species) [taxon 9606], Saururus chinensis (species) [taxon 54806], Rhodiola rosea (rose-root, species) [taxon 203015]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12607475/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12607475/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12607475/full.md

---
Source: https://tomesphere.com/paper/PMC12607475